In what might be the biggest step forward in blood-glucose metering technology in years, Intuity Medical, based in Sunnyvale, Calif., just received clearance from the U.S. Food and Drug Administration to market its Pogo Automatic Blood Glucose Monitoring System. When we can finally get our hands on one, and if Intuity’s claims for the device are valid, we will have the quickest, simplest, most discreet blood glucose meter ever made. While it’s taking a while to finally arrive, it sounds like it will be worth the wait.
Robin Gaffney, Intuity Medical’s Head of Marketing, tells me that they plan to launch the Pogo sometime next year. They haven’t finalized pricing yet, though, nor have I been able to get a device for review.
A long time coming
I still remember how impressed I was when I saw a prototype of the Pogo almost eight years ago at the American Diabetes Association’s annual convention in San Francisco. In fact, as long ago as April 2003, in my “Blood Glucose Meters” directory, I cited Intuity Medical by its former name, Rosedale Medical, as working on a blood glucose meter. So I asked Ms. Gaffney why it took Intuity Medical so long to get FDA clearance for its first meter.
“We submitted the Pogo Automatic Blood Glucose Monitoring System in the fall of 2015,” she told me. “So it took approximately eight months. Before that, we took the necessary time with the FDA to educate them on this unique and unprecedented technology, while also using the time internally to further finalize the technology and conduct clinical research with patients. There’s a lot of engineering work behind creating an easy, one-step testing solution like Pogo.”
Intuity Medical’s website has a page, Hassles of Testing, that clearly shows how you have to take 16 to 20 separate steps to check your blood glucose when you use any other meter. The Pogo reduces this hassle to the absolute minimum — one step. This simplicity will help you the most when you have to test in public, and especially in a crowded place like public transportation or a theater. Also, if you have to test several times a day, I expect that you will also appreciate how easy and quick testing will become.
Just press it
With the Pogo, all you will have to do is to press the test button. The Pogo will automatically draw blood from your finger, analyze your blood sample, and display a result.
Even better, this meter needs only 0.25 microliters of blood. The company tells me that it doesn’t know of any other blood glucose meter that can provide a glucose result with such a tiny blood sample. Even Abbott’s FreeStyle meters, the current leader, takes a bit more.
A small package
Surprisingly, for such a complete metering package, the Pogo will be quite small. “It’s shorter than an iPhone 4 and weighs less,” Ms. Gaffney says.
“It can easily fit in a pocket or purse,” she says, “and doesn’t require the use of a zippered case since all supplies are contained within the cartridge, which is in the meter.” She says that they also designed the Pogo to be used with either the right or left hand.
While an integrated meter called the Mendor Discreet has been available in Europe for the past five years, the FDA has never approved it for sale in the United States. The Pogo is smaller and also automates the entire testing process without the necessity of changing lancets or disposing of used test strips and used lancets separately.
One of the company’s pre-marketing studies of the Pogo asked 287 people to compare it to their current meters. Nine out of 10 reportedly preferred the Pogo.
The name of the meter evolved from this research with people with diabetes. “We presented several options to them,” Ms. Gaffney told me. The name Pogo “magically bubbled up from the discussions.”
Pogo. Think of it as standing for “Press Once and Go”
See more helpful articles:
David Mendosa is a journalist who learned in 1994 that he has type 2 diabetes, which he now writes about exclusively. He has written thousands of diabetes articles, two books about it, created one of the first diabetes websites, and publishes the month newsletter, “Diabetes Update.” His very low-carbohydrate diet, current A1C level of 5.3, and BMI of 19.8 keeps his diabetes in remission without any drugs.
David Mendosa was a journalist who learned in 1994 that he had type 2 diabetes, which he wrote about exclusively. He died in May 2017 after a short illness unrelated to diabetes. He wrote thousands of diabetes articles, two books about it, created one of the first diabetes websites, and published a monthly newsletter, “Diabetes Update.” His very low-carbohydrate diet, A1C level of 5.3, and BMI of 19.8 kept his diabetes in remission without any drugs until his death.